Therapeutic Targeting of Pancreatic Cancer via EphA2 Dimeric Agonistic Agents is a research paper published in Pharmaceuticals (2020). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: CA168517
National Institutes of Health
Grant: NS107479
National Institutes of Health
Grant: CA242620
NCI NIH HHS
Grant: R01 CA168517
NINDS NIH HHS
Grant: R01 NS107479
NIGMS NIH HHS
Grant: P41 GM103311
National Institutes of Health
Grant: 5R01CA168517-03
Mcl-1 in apoptosis and signal transduction: a structure/function approach
National Institutes of Health
Grant: 5P41GM103311-36
Resource for Biocomputing Visualization and Informatics
National Institutes of Health
Grant: 1P20CA242620-01
2/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership
National Institutes of Health
Grant: 5R01NS107479-08
Targeting the EphA4 in motor neuron disease: a structure-based approach
Fields of Study
Keywords
Sustainable Development Goals